These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 8971882

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of individual plasma lipoprotein(a) variations in vivo on its competition with plasminogen for fibrin and cell binding: An in vitro study using plasma from children with idiopathic nephrotic syndrome.
    Soulat T, Loyau S, Baudouin V, Maisonneuve L, Hurtaud-Roux MF, Schlegel N, Loirat C, Anglés-Cano E.
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):575-84. PubMed ID: 10669658
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
    Wanner C, Rader D, Bartens W, Krämer J, Brewer HB, Schollmeyer P, Wieland H.
    Ann Intern Med; 1993 Aug 15; 119(4):263-9. PubMed ID: 8328733
    [Abstract] [Full Text] [Related]

  • 5. Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome.
    Brown CD, Azrolan N, Thomas L, Roberts KG, Bostom A, Zhao ZH, Friedman EA.
    Am J Kidney Dis; 1995 Jul 15; 26(1):170-7. PubMed ID: 7611249
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lipoprotein(a) levels in the nephrotic syndrome.
    Kanno H, Saito E, Fujioka T, Yasugi T.
    Intern Med; 1992 Aug 15; 31(8):1004-8. PubMed ID: 1477459
    [Abstract] [Full Text] [Related]

  • 8. Elevated serum β₂-GPI-Lp(a) complexes levels in children with nephrotic syndrome.
    Zhang C, Luo Y, Huang Z, Xia Z, Cai X, Yang Y, Niu D, Wang J.
    Clin Chim Acta; 2012 Oct 09; 413(19-20):1657-60. PubMed ID: 22609258
    [Abstract] [Full Text] [Related]

  • 9. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C, Bartens W, Nauck M, Zäuner I, Greiber S, Schollmeyer P.
    Miner Electrolyte Metab; 1996 Oct 09; 22(1-3):26-30. PubMed ID: 8676820
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria.
    Joven J, Simó JM, Vilella E, Camps J, Espinel E, Villabona C.
    Clin Chem; 1995 Jun 09; 41(6 Pt 1):908-13. PubMed ID: 7768011
    [Abstract] [Full Text] [Related]

  • 12. The level of native and oxidized lipoprotein(a) in children with nephrotic syndrome.
    Li HQ, Wu J, Niu DM, Shi YH, Zhang CN, Wang JJ.
    Clin Biochem; 2012 Jan 09; 45(1-2):101-5. PubMed ID: 22122998
    [Abstract] [Full Text] [Related]

  • 13. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.
    Querfeld U, Lang M, Friedrich JB, Kohl B, Fiehn W, Schärer K.
    Pediatr Res; 1993 Dec 09; 34(6):772-6. PubMed ID: 8108191
    [Abstract] [Full Text] [Related]

  • 14. The apolipoprotein(a) size polymorphism is associated with nephrotic syndrome.
    Kronenberg F, Lingenhel A, Lhotta K, Rantner B, Kronenberg MF, König P, Thiery J, Koch M, von Eckardstein A, Dieplinger H.
    Kidney Int; 2004 Feb 09; 65(2):606-12. PubMed ID: 14717931
    [Abstract] [Full Text] [Related]

  • 15. Serum lipoprotein (a) concentration in patients with nephrotic syndrome and its clinical implication.
    Yang X, Wang H, Zhu Z, Deng A.
    J Tongji Med Univ; 1998 Feb 09; 18(4):236-8. PubMed ID: 10806854
    [Abstract] [Full Text] [Related]

  • 16. Lipoprotein(a) in nephrotic syndrome.
    Stenvinkel P, Berglund L, Heimbürger O, Pettersson E, Alvestrand A.
    Kidney Int; 1993 Nov 09; 44(5):1116-23. PubMed ID: 8264144
    [Abstract] [Full Text] [Related]

  • 17. Low-density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome.
    Stenvinkel P, Berglund L, Ericsson S, Alvestrand A, Angelin B, Eriksson M.
    Eur J Clin Invest; 1997 Feb 09; 27(2):169-77. PubMed ID: 9061312
    [Abstract] [Full Text] [Related]

  • 18. Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy?
    Kronenberg F, Lingenhel A, Lhotta K, Rantner B, Kronenberg MF, König P, Thiery J, Koch M, von Eckardstein A, Dieplinger H.
    Kidney Int; 2004 Jul 09; 66(1):348-54. PubMed ID: 15200443
    [Abstract] [Full Text] [Related]

  • 19. A study of the clinical significance of lipoprotein (a) in nephrotic syndrome.
    Takegoshi T, Kitoh C, Haba T, Hirai J, Wakasugi T, Saga T, Yamazaki Y, Mabuchi H.
    Jpn J Med; 1991 Jul 09; 30(1):21-5. PubMed ID: 1830908
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.